Metastatic Breast Cancer Research
Details Opportunity Name Breast Cancer Canada/AstraZeneca - Metastatic Breast Cancer Research Agency Breast Cancer Canada/AstraZeneca Value $100,000 Indirect Costs TBD Duration Not stated Deadlines Letter of Intent (LOI) due at ORS for optional full review 09-19-2025 Letter of Intent (LOI) due at ORS for mandatory review 10-01-2025 LOI due at agency 10-03-2025 Application due to FSc […]
